In 4 year old children, does having received a birth dose of acellular pertussis vaccine compared to not having received a birth dose of acellular pertussis vaccine affect immunogenicity and safety before and after a booster dose of an acellular pertussis vaccine.

Trial Profile

In 4 year old children, does having received a birth dose of acellular pertussis vaccine compared to not having received a birth dose of acellular pertussis vaccine affect immunogenicity and safety before and after a booster dose of an acellular pertussis vaccine.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs DTaP poliovirus vaccine (Primary) ; Measles mumps and rubella virus vaccine
  • Indications Pertussis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top